Perioperative Blood Loss Management in Total Joint Arthroplasty
Abstract
Minimizing blood loss in total joint arthroplasty (TJA) involves multiple interdisciplinary approaches and has experienced significant evolution over the last decade. TJA often requires post-operative blood transfusion, conferring significant risks upon TJA patients. Minimizing these risks by limiting blood loss has garnered recent interest. Variable strategies have been developed to manage perioperative bleeding, such as autologous donation, electrocautery, hemodilution, blood salvage systems, tourniquets, controlled hypotension, lower transfusion triggers, erythropoietic stimulating agents, and antifibrinolytics. This study reviews current blood loss reduction techniques and underscores the importance of antifibrinolytics and their impact on transfusion reduction.
Keywords
Full Text:
Subscribers OnlyReferences
Eubanks, J. D. (2010). Antifibrinolytics in major orthopaedic surgery. J Am Acad Orthop Surg, 18(3), 132-138.
Feagan, B. G., Wong, C. J., Lau, C. Y., Wheeler, S. L., Sue, A. Q. G., & Kirkley, A. (2001). Transfusion practice in elective orthopaedic surgery. Transfus Med, 11(2), 87-95.
Keating, E. M., Meding, J. B., Faris, P. M., & Ritter, M. A. (1998). Predictors of transfusion risk in elective knee surgery. Clin Orthop Relat Res(357), 50-59.
Levy, O., Martinowitz, U., Oran, A., Tauber, C., & Horoszowski, H. (1999). The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg Am, 81(11), 1580-1588.
Nelson, C. L., & Bowen, W. S. (1986). Total hip arthroplasty in Jehovah's Witnesses without blood transfusion. J Bone Joint Surg Am, 68(3), 350-353.
Pierson, J. L., Hannon, T. J., & Earles, D. R. (2004). A blood-conservation algorithm to reduce blood transfusions after total hip and knee arthroplasty. J Bone Joint Surg Am, 86-a(7), 1512-1518.
Samama, C. M. (2004). A direct antifibrinolytic agent in major orthopedic surgery. Orthopedics, 27(6 Suppl), s675-680.
Callaghan, J. J., O'Rourke, M. R., & Liu, S. S. (2005). Blood management: issues and options. J Arthroplasty, 20(4 Suppl 2), 51-54.
Bell, T. H., Berta, D., Ralley, F., Macdonald, S. J., McCalden, R. W., Bourne, R. B., . . . Naudie, D. D. (2009). Factors affecting perioperative blood loss and transfusion rates in primary total joint arthroplasty: a prospective analysis of 1642 patients. Can J Surg, 52(4), 295-301.
Burkart, B. C., Bourne, R. B., Rorabeck, C. H., Kirk, P. G., & Nott, L. (1994). The efficacy of tourniquet release in blood conservation after total knee arthroplasty. Clin Orthop Relat Res(299), 147-152.
Cushner, F. D., & Friedman, R. J. (1991). Blood loss in total knee arthroplasty. Clin Orthop Relat Res(269), 98-101.
Fauno, P., Suomalainen, O., Rehnberg, V., Hansen, T. B., Kroner, K., Soimakallio, S., & Nielsen, E. (1994). Prophylaxis for the prevention of venous thromboembolism after total knee arthroplasty. A comparison between unfractionated and low-molecular-weight heparin. J Bone Joint Surg Am, 76(12), 1814-1818.
Fragen, R. J., Stulberg, S. D., Wixson, R., Glisson, S., & Librojo, E. (1995). Effect of ketorolac tromethamine on bleeding and on requirements for analgesia after total knee arthroplasty. J Bone Joint Surg Am, 77(7), 998-1002.
Goodnough, L. T., Verbrugge, D., & Marcus, R. E. (1995). The relationship between hematocrit, blood lost, and blood transfused in total knee replacement. Implications for postoperative blood salvage and reinfusion. Am J Knee Surg, 8(3), 83-87.
Hiippala, S. T., Strid, L. J., Wennerstrand, M. I., Arvela, J. V., Niemela, H. M., Mantyla, S. K., Ylinen, J. E. (1997). Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg, 84(4), 839-844.
Karnezis, T. A., Stulberg, S. D., Wixson, R. L., & Reilly, P. (1994). The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double-blind randomized trial. J Bone Joint Surg Am, 76(10), 1545-1550.
Knight, J. L., Sherer, D., & Guo, J. (1998). Blood transfusion strategies for total knee arthroplasty: minimizing autologous blood wastage, risk of homologous blood transfusion, and transfusion cost. J Arthroplasty, 13(1), 70-76.
Lemos, M. J., & Healy, W. L. (1996). Blood transfusion in orthopaedic operations. J Bone Joint Surg Am, 78(8), 1260-1270.
Mylod, A. G., Jr., France, M. P., Muser, D. E., & Parsons, J. R. (1990). Perioperative blood loss associated with total knee arthroplasty. A comparison of procedures performed with and without cementing. J Bone Joint Surg Am, 72(7), 1010-1012.
Miller, R. D., & von Ehrenburg, W. (1995). Controversies in transfusion medicine: indications for autologous and allogeneic transfusion should be the same: con. Transfusion, 35(5), 450-452.
Spence, R. K. (1998). Anemia in the patient undergoing surgery and the transfusion decision. A review. Clin Orthop Relat Res(357), 19-29.
Murphy, P., Heal, J. M., & Blumberg, N. (1991). Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion, 31(3), 212-217.
Blumberg, N., & Heal, J. M. (1988). Evidence for plasma-mediated immunomodulation--transfusions of plasma-rich blood components are associated with a greater risk of acquired immunodeficiency syndrome than transfusions of red blood cells alone. Transplant Proc, 20(6), 1138-1142.
Blumberg, N., & Heal, J. M. (1996). Immunomodulation by blood transfusion: an evolving scientific and clinical challenge. Am J Med, 101(3), 299-308. doi:10.1016/s0002-9343(96)00124-6
Blumberg, N., Heal, J. M., Murphy, P., Agarwal, M. M., & Chuang, C. (1986). Association between transfusion of whole blood and recurrence of cancer. Br Med J (Clin Res Ed), 293(6546), 530-533.
Brunson, M. E., & Alexander, J. W. (1990). Mechanisms of transfusion-induced immunosuppression. Transfusion, 30(7), 651-658.
Cone, J., Day, L. J., Johnson, G. K., Murray, D. G., & Nelson, C. L. (1990). Blood products: optimal use, conservation, and safety. Instr Course Lect, 39, 431-434.
Stevens, C. E., Aach, R. D., Hollinger, F. B., Mosley, J. W., Szmuness, W., Kahn, R., . . . Edwards, V. (1984). Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med, 101(6), 733-738.
Friedman, R., Homering, M., Holberg, G., & Berkowitz, S. D. (2014). Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am, 96(4), 272-278. doi:10.2106/jbjs.l.01268
Kagoma, Y. K., Crowther, M. A., Douketis, J., Bhandari, M., Eikelboom, J., & Lim, W. (2009). Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res, 123(5), 687-696. doi:10.1016/j.thromres.2008.09.015
Mercuriali, F., & Inghilleri, G. (1999). Transfusion risks and limitations. Minerva Anestesiol, 65(5), 286-292.
Rao, S. V., Eikelboom, J. A., Granger, C. B., Harrington, R. A., Califf, R. M., & Bassand, J. P. (2007). Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J, 28(10), 1193-1204. doi:10.1093/eurheartj/ehm019
Cole, J. W., Murray, D. J., Snider, R. J., Bassett, G. S., Bridwell, K. H., & Lenke, L. G. (2003). Aprotinin reduces blood loss during spinal surgery in children. Spine (Phila Pa 1976), 28(21), 2482-2485. doi:10.1097/01.brs.0000090835.45437.7f
Copley, L. A., Richards, B. S., Safavi, F. Z., & Newton, P. O. (1999). Hemodilution as a method to reduce transfusion requirements in adolescent spine fusion surgery. Spine (Phila Pa 1976), 24(3), 219-222; discussion 223-214.
Meert, K. L., Kannan, S., & Mooney, J. F. (2002). Predictors of red cell transfusion in children and adolescents undergoing spinal fusion surgery. Spine (Phila Pa 1976), 27(19), 2137-2142. doi:10.1097/01.brs.0000025691.54848.d0
Murray, D. J., Forbes, R. B., Titone, M. B., & Weinstein, S. L. (1997). Transfusion management in pediatric and adolescent scoliosis surgery. Efficacy of autologous blood. Spine (Phila Pa 1976), 22(23), 2735-2740.
Thompson, G. H., Florentino-Pineda, I., & Poe-Kochert, C. (2005). The role of amicar in decreasing perioperative blood loss in idiopathic scoliosis. Spine (Phila Pa 1976), 30(17 Suppl), S94-99.
Autologous blood transfusions. Council on Scientific Affairs. (1986). Jama, 256(17), 2378-2380.
Consensus conference. Perioperative red blood cell transfusion. (1988). Jama, 260(18), 2700-2703.
Atlas, S. J., Singer, D. E., & Skates, S. J. (1994). Changing blood use in the AIDS era: the case of elective hip surgery. Transfusion, 34(5), 386-391.
Billote, D. B., Glisson, S. N., Green, D., & Wixson, R. L. (2002). A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am, 84-a(8), 1299-1304.
Birkmeyer, J. D., Goodnough, L. T., AuBuchon, J. P., Noordsij, P. G., & Littenberg, B. (1993). The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion, 33(7), 544-551.
Cohen, J. A., & Brecher, M. E. (1995). Preoperative autologous blood donation: benefit or detriment? A mathematical analysis. Transfusion, 35(8), 640-644.
Etchason, J., Petz, L., Keeler, E., Calhoun, L., Kleinman, S., Snider, C., . . . Brook, R. (1995). The cost effectiveness of preoperative autologous blood donations. N Engl J Med, 332(11), 719-724. doi:10.1056/nejm199503163321106
Giordano, G. F., Dockery, J., Wallace, B. A., Donohoe, K. M., Rivers, S. L., Bass, L. J., . . . Sandler, S. G. (1991). An autologous blood program coordinated by a regional blood center: a 5-year experience. Transfusion, 31(6), 509-512.
Goodnough, L. T., Brecher, M. E., Kanter, M. H., & AuBuchon, J. P. (1999). Transfusion medicine. Second of two parts--blood conservation. N Engl J Med, 340(7), 525-533. doi:10.1056/nejm199902183400706
Lee, S. J., Liljas, B., Churchill, W. H., Popovsky, M. A., Stowell, C. P., Cannon, M. E., & Johannesson, M. (1998). Perceptions and preferences of autologous blood donors. Transfusion, 38(8), 757-763.
Toy, P. T., Strauss, R. G., Stehling, L. C., Sears, R., Price, T. H., Rossi, E. C., . . . et al. (1987). Predeposited autologous blood for elective surgery. A national multicenter study. N Engl J Med, 316(9), 517-520. doi:10.1056/nejm198702263160906
Welch, H. G., Meehan, K. R., & Goodnough, L. T. (1992). Prudent strategies for elective red blood cell transfusion. Ann Intern Med, 116(5), 393-402.
Mauerhan, D. R., Nussman, D., Mokris, J. G., & Beaver, W. B. (1993). Effect of postoperative reinfusion systems on hemoglobin levels in primary total hip and total knee arthroplasties. A prospective randomized study. J Arthroplasty, 8(5), 523-527.
Popovsky, M. A., Whitaker, B., & Arnold, N. L. (1995). Severe outcomes of allogeneic and autologous blood donation:
frequency and characterization. Transfusion, 35(9), 734-737.
Sculco, T. P. (1998). Global blood management in orthopaedic surgery. Clin Orthop Relat Res(357), 43-49.
Tsumara, N., Yoshiya, S., Chin, T., Shiba, R., Kohso, K., & Doita, M. (2006). A prospective comparison of clamping the drain or post-operative salvage of blood in reducing blood loss after total knee arthroplasty. J Bone Joint Surg Br, 88(1), 49-53. doi:10.1302/0301-620x.88b1.16653
Adalberth, G., Bystrom, S., Kolstad, K., Mallmin, H., & Milbrink, J. (1998). Postoperative drainage of knee arthroplasty is not necessary: a randomized study of 90 patients. Acta Orthop Scand, 69(5), 475-478.
Clements, D. H., Sculco, T. P., Burke, S. W., Mayer, K., & Levine, D. B. (1992). Salvage and reinfusion of postoperative sanguineous wound drainage. A preliminary report. J Bone Joint Surg Am, 74(5), 646-651.
Gannon, D. M., Lombardi, A. V., Jr., Mallory, T. H., Vaughn, B. K., Finney, C. R., & Niemcryk, S. (1991). An evaluation of the efficacy of postoperative blood salvage after total joint arthroplasty. A prospective randomized trial. J Arthroplasty, 6(2), 109-114.
Groh, G. I., Buchert, P. K., & Allen, W. C. (1990). A comparison of transfusion requirements after total knee arthroplasty using the Solcotrans autotransfusion system. J Arthroplasty, 5(3), 281-285.
Han, C. D., & Shin, D. E. (1997). Postoperative blood salvage and reinfusion after total joint arthroplasty. J Arthroplasty, 12(5), 511-516.
Martin, J. W., Whiteside, L. A., Milliano, M. T., & Reedy, M. E. (1992). Postoperative blood retrieval and transfusion in cementless total knee arthroplasty. J Arthroplasty, 7(2), 205-210.
Sinha, A., Sinha, M., & Burgert, S. (2001). Reinfusion of drained blood as an alternative to homologous blood transfusion after total knee replacement. Int Orthop, 25(4), 257-259.
Hand, G. C., Henderson, M., Mace, P., Sherif, N., Newman, J. H., & Goldie, D. J. (1998). Methyl methacrylate levels in unwashed salvage blood following unilateral total knee arthroplasty. J Arthroplasty, 13(5), 576-579.
Handel, M., Winkler, J., Hornlein, R. F., Northoff, H., Heeg, P., Teschner, M., & Sell, S. (2001). Increased interleukin-6 in collected drainage blood after total knee arthroplasty: an association with febrile reactions during retransfusion. Acta Orthop Scand, 72(3), 270-272. doi:10.1080/00016470152846600
Murray, D. J., Gress, K., & Weinstein, S. L. (1992). Coagulopathy after reinfusion of autologous scavenged red blood cells. Anesth Analg, 75(1), 125-129.
Southern, E. P., Huo, M. H., Mehta, J. R., & Keggi, K. J. (1995). Unwashed wound drainage blood. What are we giving our patients? Clin Orthop Relat Res(320), 235-246.
Bezwada, H. P., Nazarian, D. G., Henry, D. H., & Booth, R. E., Jr. (2003). Preoperative use of recombinant human erythropoietin before total joint arthroplasty. J Bone Joint Surg Am, 85-a(9), 1795-1800.
Juelsgaard, P., Larsen, U. T., Sorensen, J. V., Madsen, F., & Soballe, K. (2001). Hypotensive epidural anesthesia in total knee replacement without tourniquet: reduced blood loss and transfusion. Reg Anesth Pain Med, 26(2), 105-110. doi:10.1053/rapm.2001.21094
Sharrock, N. E., Mineo, R., Urquhart, B., & Salvati, E. A. (1993). The effect of two levels of hypotension on intraoperative blood loss during total hip arthroplasty performed under lumbar epidural anesthesia. Anesth Analg, 76(3), 580-584.
Healy, W. L., Seidman, J., Pfeifer, B. A., & Brown, D. G. (1994). Cold compressive dressing after total knee arthroplasty. Clin Orthop Relat Res(299), 143-146.
Marmor, L., Avoy, D. R., & McCabe, A. (1991). Effect of fibrinogen concentrates on blood loss in total knee arthroplasty. Clin Orthop Relat Res(273), 136-138.
Neilipovitz, D. T. (2004). Tranexamic acid for major spinal surgery. Eur Spine J, 13 Suppl 1, S62-65. doi:10.1007/s00586-004-0716-2
Yang, X., Alexander, K. P., Chen, A. Y., Roe, M. T., Brindis, R. G., Rao, S. V., . . . Peterson, E. D. (2005). The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol, 46(8), 1490-1495. doi:10.1016/j.jacc.2005.06.072
Hardy, J. F., & Desroches, J. (1992). Natural and synthetic antifibrinolytics in cardiac surgery. Can J Anaesth, 39(4), 353-365. doi:10.1007/bf03009046
Kruithof, E. K., Nicolosa, G., & Bachmann, F. (1987). Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation. Blood, 70(5), 1645-1653.
Petaja, J., Myllynen, P., Myllyla, G., & Vahtera, E. (1987). Fibrinolysis after application of a pneumatic tourniquet. Acta Chir Scand, 153(11-12), 647-651.
Dunn, C. J., & Goa, K. L. (1999). Tranexamic acid: a review of its use in surgery and other indications. Drugs, 57(6), 1005-1032.
Yang, Z. G., Chen, W. P., & Wu, L. D. (2012). Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am, 94(13), 1153-1159. doi:10.2106/jbjs.k.00873
Benoni, G., Lethagen, S., & Fredin, H. (1997). The effect of tranexamic acid on local and plasma fibrinolysis during total knee arthroplasty. Thromb Res, 85(3), 195-206.
Cid, J., & Lozano, M. (2005). Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion, 45(8), 1302-1307. doi:10.1111/j.1537-2995.2005.00204.x
Ellis, M. H., Fredman, B., Zohar, E., Ifrach, N., & Jedeikin, R. (2001). The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. J Clin Anesth, 13(7), 509-513.
Hynes, M., Calder, P., & Scott, G. (2003). The use of tranexamic acid to reduce blood loss during total knee arthroplasty. Knee, 10(4), 375-377.
Lindoff, C., Rybo, G., & Astedt, B. (1993). Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb Haemost, 70(2), 238-240.
DOI: http://dx.doi.org/10.18103/imr.v2i7.137
Refbacks
- There are currently no refbacks.